Inogen Inc (INGN) posted its first US sales growth since Q4 2024, closed its rental business divestiture, and unveiled $20 million in new annualized cost savings despite a 2.4% revenue decline.
Inogen (NASDAQ:INGN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Inogen faces margin pressure and slow growth; divestment may lift income and buybacks. Click to read this latest analysis of INGN stock.
Inogen has chosen make the divestiture amid declining revenues for the segment.
Inogen (INGN) agreed to sell its US oxygen rental business to Rotech Healthcare for up to $25 millio
INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.
This is the newest page. Registered accounts read further back.